Dillon & Associates’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,031
Closed -$293K 67
2020
Q3
$293K Sell
1,031
-320
-24% -$90.9K 0.07% 58
2020
Q2
$362K Hold
1,351
0.1% 53
2020
Q1
$427K Sell
1,351
-100
-7% -$31.6K 0.14% 52
2019
Q4
$431K Sell
1,451
-425
-23% -$126K 0.12% 53
2019
Q3
$437K Sell
1,876
-930
-33% -$217K 0.13% 51
2019
Q2
$657K Sell
2,806
-60
-2% -$14K 0.2% 50
2019
Q1
$676K Buy
2,866
+45
+2% +$10.6K 0.22% 47
2018
Q4
$849K Buy
2,821
+105
+4% +$31.6K 0.32% 41
2018
Q3
$959K Buy
2,716
+95
+4% +$33.5K 0.32% 40
2018
Q2
$760K Buy
2,621
+397
+18% +$115K 0.28% 43
2018
Q1
$609K Buy
2,224
+569
+34% +$156K 0.24% 48
2017
Q4
$528K Buy
1,655
+185
+13% +$59K 0.2% 51
2017
Q3
$460K Buy
1,470
+10
+0.7% +$3.13K 0.18% 53
2017
Q2
$396K Sell
1,460
-325
-18% -$88.2K 0.16% 56
2017
Q1
$487K Buy
1,785
+5
+0.3% +$1.36K 0.21% 55
2016
Q4
$506K Buy
1,780
+40
+2% +$11.4K 0.23% 53
2016
Q3
$545K Buy
1,740
+60
+4% +$18.8K 0.25% 52
2016
Q2
$407K Buy
1,680
+245
+17% +$59.4K 0.19% 56
2016
Q1
$373K Buy
1,435
+265
+23% +$68.9K 0.17% 56
2015
Q4
$358K Buy
1,170
+65
+6% +$19.9K 0.17% 55
2015
Q3
$323K Buy
1,105
+203
+23% +$59.3K 0.16% 59
2015
Q2
$364K Buy
902
+157
+21% +$63.4K 0.18% 54
2015
Q1
$314K Buy
745
+45
+6% +$19K 0.15% 56
2014
Q4
$237K Sell
700
-45
-6% -$15.2K 0.12% 60
2014
Q3
$247K Hold
745
0.13% 60
2014
Q2
$234K Hold
745
0.12% 58
2014
Q1
$228K Hold
745
0.12% 58
2013
Q4
$209K Buy
+745
New +$209K 0.11% 59